TELA Bio, Inc. (TELA)
NASDAQ: TELA · IEX Real-Time Price · USD
4.605
-0.025 (-0.54%)
Jul 22, 2024, 10:02 AM EDT - Market open
TELA Bio Employees
TELA Bio had 227 employees as of December 31, 2023. The number of employees increased by 54 or 31.21% compared to the previous year.
Employees
227
Change (1Y)
54
Growth (1Y)
31.21%
Revenue / Employee
$278,181
Profits / Employee
-$177,524
Market Cap
114.65M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 227 | 54 | 31.21% |
Dec 31, 2022 | 173 | 50 | 40.65% |
Dec 31, 2021 | 123 | 15 | 13.89% |
Dec 31, 2020 | 108 | 19 | 21.35% |
Dec 31, 2019 | 89 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Augmedix | 1,430 |
American Well | 1,104 |
FONAR | 561 |
Akoya Biosciences | 330 |
Karyopharm Therapeutics | 325 |
Adagene | 174 |
RAPT Therapeutics | 131 |
KORU Medical Systems | 82 |
TELA News
- 6 weeks ago - TELA Bio Appoints Jeffrey Blizard to its Board of Directors - GlobeNewsWire
- 2 months ago - TELA Bio Appoints Greg Firestone as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - TELA Bio Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - TELA Bio to Announce First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures - GlobeNewsWire
- 3 months ago - TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy - GlobeNewsWire
- 4 months ago - TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results - GlobeNewsWire